news Archives - Page 59 of 100 - Journal for Clinical Studies

Current Edition

Europe

Merck Collaborates with LifeNet Health to give Researchers Access to High-Quality Hepatocytes for Drug Development

Merck and LifeNet Health are collaborating to provide researchers with access to high-quality Primary Human Hepatocytes (PHH) that represent both normal and diseased ...

27 February 2018 Europe | news

Continue Reading →

news

Webinar to Reveal Data Supporting the Use of MuScreen(TM) for Preclinical Immunotherapeutic Development

Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing tran...

27 February 2018 news | North America

Continue Reading →

Asia Pacific

Scientists in Korea develop biosensing lens for diabetics

The research team expects that the release of this device will offer diabetics a pain-free way to measure their glucose levels with the blink of an eye. [caption id="...

27 February 2018 Asia Pacific | news

Continue Reading →

Europe

Clintec International Expands Capabilities with the Accreditation of the Latest Generation of Medidata Rave EDC

Clintec International, an award winning, global Clinical Research Organisation (CRO), enhances its data management capabilities to include Medidata’s (NASDAQ: MDSO) l...

27 February 2018 Europe | news

Continue Reading →

Europe

CRF Health Scoops 2018 TrialConsent® Hat Trick as CARE Award Finalist

Shortlisted as Best Patient-Focused Technological Development in Clinical & Research Excellence Awards (CARE) Awards CRF Health, the leading provider of patient-c...

27 February 2018 Europe | news

Continue Reading →

Asia Pacific

TWi Biotechnology gets TFDA nod to treat Inherited Epidermolysis Bullosa

TFDA approves phase 2 clinical trial of AC-203 for the treatment of inherited Epidermolysis Bullosa (EB) TWi Biotechnology,a clinical stage biotechnology company foc...

27 February 2018 Asia Pacific | news

Continue Reading →

Australasia

Merck snaps up Australian firm Viralytics for $394M

The deal gives Merck access to Viralytics’s investigational oncolytic immunotherapy Cavatak, that has been shown to preferentially infect and kill cancer cells. &nbs...

27 February 2018 Australasia | news

Continue Reading →

Asia Pacific

New live attenuated TB vaccine is safe and shows a distinct, dose dependent immune response in a Phase1b trial in newborns

Biofabri, the University of Zaragoza, the South African Tuberculosis Vaccine Initiative (SATVI) and TB Vaccine Initiative (TBVI) announced the results of a Phase 1b t...

22 February 2018 Asia Pacific | Europe | news

Continue Reading →

news

Drug-eluting balloon trial results indicate positive outlook for Boston Scientific’s entrance into the US market, says GlobalData

In January 2018, Boston Scientific announced results from a first-of-its-kind trial comparing its Ranger drug-coated balloon (DCB) to Medtronic’s In.Pact Admiral DCB,...

22 February 2018 news | North America

Continue Reading →

Asia Pacific

Researchers in Japan develop a novel biosensing method

The group has developed a nonlinear optical crystal (NLOC) chip, which combines terahertz (THz) waves with a microfluidic device. A group of researchers from Osaka U...

21 February 2018 Asia Pacific | news

Continue Reading →